BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 25065585)

  • 1. The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.
    Aftab MN; Dinger ME; Perera RJ
    Arch Biochem Biophys; 2014 Dec; 563():60-70. PubMed ID: 25065585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between small and long non-coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces.
    Riefolo M; Porcellini E; Dika E; Broseghini E; Ferracin M
    Mol Oncol; 2019 Jan; 13(1):74-98. PubMed ID: 30499222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNAs in melanoma.
    Yu X; Zheng H; Tse G; Chan MT; Wu WK
    Cell Prolif; 2018 Aug; 51(4):e12457. PubMed ID: 29582492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA ILF3-AS1 promotes cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma.
    Chen X; Liu S; Zhao X; Ma X; Gao G; Yu L; Yan D; Dong H; Sun W
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.
    Ross CL; Kaushik S; Valdes-Rodriguez R; Anvekar R
    J Cell Physiol; 2018 Jul; 233(7):5133-5141. PubMed ID: 29226953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of long non-coding RNAs in cutaneous melanoma.
    Leucci E; Coe EA; Marine JC; Vance KW
    Pigment Cell Melanoma Res; 2016 Nov; 29(6):619-626. PubMed ID: 27606977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
    Leibowitz-Amit R; Sidi Y; Avni D
    Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNAs and melanoma: From diagnosis to therapy.
    Dashti F; Mirazimi SMA; Kazemioula G; Mohammadi M; Hosseini M; Razaghi Bahabadi Z; Mirazimi MS; Abadi MHJN; Shahini A; Afshari M; Mirzaei H
    Pathol Res Pract; 2023 Jan; 241():154232. PubMed ID: 36528985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
    Sun M; Liu XH; Lu KH; Nie FQ; Xia R; Kong R; Yang JS; Xu TP; Liu YW; Zou YF; Lu BB; Yin R; Zhang EB; Xu L; De W; Wang ZX
    Cell Death Dis; 2014 Jun; 5(6):e1298. PubMed ID: 24967960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Review on the Clinical Relevance of Long Non-Coding RNAs in Cutaneous Melanoma.
    De Falco V; Napolitano S; Esposito D; Guerrera LP; Ciardiello D; Formisano L; Troiani T
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNAs as Key Players in the Management of Cutaneous Melanoma.
    Lorusso C; De Summa S; Pinto R; Danza K; Tommasi S
    Cells; 2020 Feb; 9(2):. PubMed ID: 32054078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.
    Segura MF; Greenwald HS; Hanniford D; Osman I; Hernando E
    Carcinogenesis; 2012 Oct; 33(10):1823-32. PubMed ID: 22693259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.
    Bennett PE; Bemis L; Norris DA; Shellman YG
    Physiol Genomics; 2013 Nov; 45(22):1049-59. PubMed ID: 24046283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
    Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
    World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of non-coding RNA in oral cancer.
    Momen-Heravi F; Bala S
    Cell Signal; 2018 Jan; 42():134-143. PubMed ID: 29056500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA HEIH promotes melanoma cell proliferation, migration and invasion via inhibition of
    Zhao H; Xing G; Wang Y; Luo Z; Liu G; Meng H
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28487474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA SPRY4-IT1 promotes proliferation and invasion by acting as a ceRNA of miR-101-3p in colorectal cancer cells.
    Jin J; Chu Z; Ma P; Meng Y; Yang Y
    Tumour Biol; 2017 Jul; 39(7):1010428317716250. PubMed ID: 28720069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNAs in cutaneous melanoma: clinical perspectives.
    Hulstaert E; Brochez L; Volders PJ; Vandesompele J; Mestdagh P
    Oncotarget; 2017 Jun; 8(26):43470-43480. PubMed ID: 28415644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22.
    Luan W; Li L; Shi Y; Bu X; Xia Y; Wang J; Djangmah HS; Liu X; You Y; Xu B
    Oncotarget; 2016 Sep; 7(39):63901-63912. PubMed ID: 27564100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA MIR205HG regulates melanomagenesis via the miR-299-3p/VEGFA axis.
    Guo J; Gan Q; Gan C; Zhang X; Ma X; Dong M
    Aging (Albany NY); 2021 Feb; 13(4):5297-5311. PubMed ID: 33535182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.